EP0303602A4 - Enzymatic synthesis. - Google Patents
Enzymatic synthesis.Info
- Publication number
- EP0303602A4 EP0303602A4 EP19870902325 EP87902325A EP0303602A4 EP 0303602 A4 EP0303602 A4 EP 0303602A4 EP 19870902325 EP19870902325 EP 19870902325 EP 87902325 A EP87902325 A EP 87902325A EP 0303602 A4 EP0303602 A4 EP 0303602A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- amino acid
- ester
- derivative
- benzyl
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000015572 biosynthetic process Effects 0.000 title description 16
- 238000003786 synthesis reaction Methods 0.000 title description 10
- 230000002255 enzymatic effect Effects 0.000 title description 2
- 238000000034 method Methods 0.000 claims abstract description 26
- 229940024606 amino acid Drugs 0.000 claims abstract description 18
- 150000001413 amino acids Chemical class 0.000 claims abstract description 18
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 16
- 108091005804 Peptidases Proteins 0.000 claims abstract description 12
- 102000035195 Peptidases Human genes 0.000 claims abstract description 12
- 235000019833 protease Nutrition 0.000 claims abstract description 12
- 150000003573 thiols Chemical class 0.000 claims abstract description 12
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims abstract description 10
- 229940009098 aspartate Drugs 0.000 claims abstract description 10
- 229930195712 glutamate Natural products 0.000 claims abstract description 9
- 150000003862 amino acid derivatives Chemical class 0.000 claims abstract description 8
- 150000001412 amines Chemical class 0.000 claims abstract description 7
- 150000002148 esters Chemical class 0.000 claims abstract description 7
- 125000000729 N-terminal amino-acid group Chemical group 0.000 claims abstract description 4
- 125000001931 aliphatic group Chemical group 0.000 claims abstract description 4
- 125000003118 aryl group Chemical group 0.000 claims abstract description 4
- 125000001165 hydrophobic group Chemical group 0.000 claims abstract description 4
- 239000004365 Protease Substances 0.000 claims description 12
- 108090000526 Papain Proteins 0.000 claims description 11
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 11
- 235000019834 papain Nutrition 0.000 claims description 10
- 229940055729 papain Drugs 0.000 claims description 10
- 108010011485 Aspartame Proteins 0.000 claims description 9
- 239000000605 aspartame Substances 0.000 claims description 9
- 229960003438 aspartame Drugs 0.000 claims description 9
- 235000010357 aspartame Nutrition 0.000 claims description 9
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 8
- 210000004899 c-terminal region Anatomy 0.000 claims description 7
- ZPVDKMKHRJFPMC-QHCPKHFHSA-N dibenzyl (2s)-2-(phenylmethoxycarbonylamino)butanedioate Chemical compound N([C@@H](CC(=O)OCC=1C=CC=CC=1)C(=O)OCC=1C=CC=CC=1)C(=O)OCC1=CC=CC=C1 ZPVDKMKHRJFPMC-QHCPKHFHSA-N 0.000 claims description 7
- 229940049906 glutamate Drugs 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 6
- VSDUZFOSJDMAFZ-VIFPVBQESA-N methyl L-phenylalaninate Chemical compound COC(=O)[C@@H](N)CC1=CC=CC=C1 VSDUZFOSJDMAFZ-VIFPVBQESA-N 0.000 claims description 6
- 125000006239 protecting group Chemical group 0.000 claims description 6
- 238000005984 hydrogenation reaction Methods 0.000 claims description 4
- 108090001069 Chymopapain Proteins 0.000 claims description 3
- ISWQCIVKKSOKNN-UHFFFAOYSA-L Tiron Chemical compound [Na+].[Na+].OC1=CC(S([O-])(=O)=O)=CC(S([O-])(=O)=O)=C1O ISWQCIVKKSOKNN-UHFFFAOYSA-L 0.000 claims description 3
- 229960002976 chymopapain Drugs 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- -1 benzyloxycarboxyl Chemical group 0.000 claims 2
- 101710097834 Thiol protease Proteins 0.000 claims 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 abstract description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 abstract description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 abstract description 2
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 abstract description 2
- 229960002591 hydroxyproline Drugs 0.000 abstract description 2
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 abstract description 2
- 238000006243 chemical reaction Methods 0.000 description 26
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 25
- 235000001014 amino acid Nutrition 0.000 description 12
- 239000000047 product Substances 0.000 description 7
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 5
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 108090000371 Esterases Proteins 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000006482 condensation reaction Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000010647 peptide synthesis reaction Methods 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- XYXYXSKSTZAEJW-VIFPVBQESA-N (2s)-2-(phenylmethoxycarbonylamino)butanedioic acid Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)OCC1=CC=CC=C1 XYXYXSKSTZAEJW-VIFPVBQESA-N 0.000 description 1
- PVFCXMDXBIEMQG-JTQLQIEISA-N (2s)-2-(phenylmethoxycarbonylamino)pentanedioic acid Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)OCC1=CC=CC=C1 PVFCXMDXBIEMQG-JTQLQIEISA-N 0.000 description 1
- MGOGKPMIZGEGOZ-REOHCLBHSA-N (2s)-2-amino-3-hydroxypropanamide Chemical compound OC[C@H](N)C(N)=O MGOGKPMIZGEGOZ-REOHCLBHSA-N 0.000 description 1
- BEXAJIYIQICKDL-HRDPVCSZSA-N (2s)-2-aminobutanedioic acid;methyl (2s)-2-amino-3-phenylpropanoate Chemical compound OC(=O)[C@@H](N)CC(O)=O.COC(=O)[C@@H](N)CC1=CC=CC=C1 BEXAJIYIQICKDL-HRDPVCSZSA-N 0.000 description 1
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 1
- QCTFKEJEIMPOLW-JURCDPSOSA-N Ala-Ile-Phe Chemical compound C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 QCTFKEJEIMPOLW-JURCDPSOSA-N 0.000 description 1
- 108010004032 Bromelains Proteins 0.000 description 1
- 102000005600 Cathepsins Human genes 0.000 description 1
- 108010084457 Cathepsins Proteins 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000270 Ficain Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 108090000794 Streptopain Proteins 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 239000008122 artificial sweetener Substances 0.000 description 1
- 150000001509 aspartic acid derivatives Chemical class 0.000 description 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- 235000019835 bromelain Nutrition 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- ROBXZHNBBCHEIQ-BYPYZUCNSA-N ethyl (2s)-2-aminopropanoate Chemical compound CCOC(=O)[C@H](C)N ROBXZHNBBCHEIQ-BYPYZUCNSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000019836 ficin Nutrition 0.000 description 1
- POTUGHMKJGOKRI-UHFFFAOYSA-N ficin Chemical compound FI=CI=N POTUGHMKJGOKRI-UHFFFAOYSA-N 0.000 description 1
- 150000002306 glutamic acid derivatives Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 229960005190 phenylalanine Drugs 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
Definitions
- the present invention relates to a method of linking either an aspartate or glutamate radical to the N-terminal of an amino acid or derivative thereof.
- This method is applicable for amino acids, with the exception of proline or hydroxy-proline, and is functional regardless of whether the amino acid is in isolation or present as the N-terminal residue of a peptide.
- the method is therefore useful in peptide synthesis.
- This method is particularly applicable to the production of the artificial sweetening agent known under the generic name of aspartame. Aspartame was first discovered in 1966 and is a dipeptide of the following structure:
- A. and A_ are amino acids or peptides.
- thiol proteinases were able to catalyse the reaction between Z-L-aspartic acid dibenzyl ester and L-phenylalanine methyl ester to form a derivate of aspartame, Z-L-aspartyl(/J-benzyl ester) -L-phenylalanine methyl ester (Z is an abbreviation used in the art that refers to benzyoxycarbonyl) . Further work has shown that this method is applicable to linking either aspartate or glutamate to the N-terminal of an amino acid derivative or peptide.
- the reaction takes advantage of the esterase activity of the thiol proteinase giving rise to a much faster and more efficient reaction than results from the use of prior art processes involving condensation reactions.
- the use of an aspartate or glutamate derivative with a free carboxyl group is a different and less efficient method with a reaction time of days as compared to minutes.
- the use of the esterase activity does not generate a free carboxyl group, rather, in the enzyme-C-component complex the ester of the C-component is cleaved by a nucleophilic attack by the amino group of the incoming N-component during formation of the peptide bond.
- the present invention consists in a method for the addition of an aspartate or glutamate radical to the N-terminal of an amino acid, wherein said amino acid exists either singly, as a derivative having a C-terminal 'o protective group, or as the N-terminal residue of a peptide, said method comprising the following steps: reacting, in the presence of a thiol proteinase, a compound of a general formula:
- n is either 1 or 2
- B- is any group capable of forming an ester linkage
- B- is any group capable of forming an ester 3o linkage and cleavable by the thiol proteinase
- X is an aliphatic or aromatic hydrophobic group, with an amino acid or derivative thereof or a peptide, the amino acid derivative having a C-terminal protective group, to obtain a compound of the following general formula:
- A is a residue of said amino acid or derivative thereof or said peptide, and optionally removing the X and B, groups from the molecule.
- the thiol proteinase is either papain or chymopapain, n is 1, X is benzyloxycarbonyl (known in the art as Z) , B, and B-, -2- . ⁇ are both benzyl groups, A is a methyl ester of phenylalanine and a hydrogenation process is used to remove the Z and B, benzyl group from the reaction product to produce aspartame.
- Thiol proteinases have been well characterized in the literature (e.g. Advances in Enzymology Vol. 53 pp 239-306) , and include the enzymes papain, chymopapain, ficin, bromelain, cathepsins B and C and Streptococcal proteinase. Apart from Z there are a number of other aliphatic or aromatic hydrophobic groups which could be used in this invention. These include t-BOC, B ' .poc, and Fmoc. The use and characteristics of these compounds has been described in the literature by Schechter I and Berger A (Biochem. Biphys. Res. Comm. Vol. 27 pp 157-162) and by Fruton J.S.
- Examples of groups which can be substituted for benzyl at B, and/or B, are ethyl or methyl groups. However the rate of reaction in the case of production of aspartame is greater when B, and B- are both benzyl.
- the protective groups for the carboxyl ⁇ group of this amine component include alkoxy groups, substituted or unsubstituted benzyloxy groups, or amino groups.
- Reaction 1 part “a” was added to 9 parts “b” at room temperature and the pH maintained at 8.5. Synthesis was monitored by high pressure liquid chromatography (HPLC) . The reaction proceeded with approximately 70 to 80% efficiency in terms of the amount of '-a" used with a reaction time of approximately 2-3 hours.
- HPLC high pressure liquid chromatography
- This conversion was carried out by a hydrogenation reaction involving a palladium catalyst and hydrogen gas.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Abstract
A process for the linking of either aspartate or glutamate radicals to the N-terminal of an amino acid or derivative thereof or to the N-terminal residue of a peptide. The process is applicable for all amino acids with the exception of proline and hydroxy-proline and involves reacting an aspartate or glutamate radical of formula (I), in which n is 1 or 2, B1 is any group capable of forming an ester linkage, B2 is any group capable of forming an ester linkage and cleavable by a thiol proteinase and X is an aliphatic or aromatic hydrophobic group, with an amino acid derivative or peptide in the presence of a thiol proteinase.
Description
ENZYMATIC SYNTHESIS
The present invention relates to a method of linking either an aspartate or glutamate radical to the N-terminal of an amino acid or derivative thereof. This method is applicable for amino acids, with the exception of proline or hydroxy-proline, and is functional regardless of whether the amino acid is in isolation or present as the N-terminal residue of a peptide. The method is therefore useful in peptide synthesis. This method is particularly applicable to the production of the artificial sweetening agent known under the generic name of aspartame. Aspartame was first discovered in 1966 and is a dipeptide of the following structure:
CH
3
Aspartic acid Phenylalanine Methyl ester
o
and has a sweetening power of 100 to 200 times that of sugar .
It is well known in the art to link amino acids enzymatically. This is witnessed by the number of patent applications relating to such processes which include US 4,086,136, US 4,116,768, US 4,289,721 and US 4,521,514 and Australian Patent No. 558330. Each of these processes involves the linking of an amino acid derivative with a free hydroxyl group to an amino acid derivative or peptide, the reaction being carried out in the presence of an enzyme. All these prior art processes involve a condensation reaction to bring about the joining of the amino acids. A general example of this type of reaction is shown below.
A-^-OH + H-A2 En2yme> Aχ - A2 + H20
where A. and A_ are amino acids or peptides.
During the course of investigations into the use' of the thiol proteinases in eπzymic peptide synthesis the present inventor discovered that thiol proteinases were able to catalyse the reaction between Z-L-aspartic acid dibenzyl ester and L-phenylalanine methyl ester to form a derivate of aspartame, Z-L-aspartyl(/J-benzyl ester) -L-phenylalanine methyl ester (Z is an abbreviation used in the art that refers to benzyoxycarbonyl) . Further work has shown that this method is applicable to linking either aspartate or glutamate to the N-terminal of an amino acid derivative or peptide.
The reaction takes advantage of the esterase activity of the thiol proteinase giving rise to a much faster and more efficient reaction than results from the use of prior art processes involving condensation reactions. The use of an aspartate or glutamate derivative with a free carboxyl group is a different and less efficient method with a reaction time of days as compared to minutes. Further it should be noted that in the present process the
use of the esterase activity does not generate a free carboxyl group, rather, in the enzyme-C-component complex the ester of the C-component is cleaved by a nucleophilic attack by the amino group of the incoming N-component during formation of the peptide bond.
The present invention consists in a method for the addition of an aspartate or glutamate radical to the N-terminal of an amino acid, wherein said amino acid exists either singly, as a derivative having a C-terminal 'o protective group, or as the N-terminal residue of a peptide, said method comprising the following steps: reacting, in the presence of a thiol proteinase, a compound of a general formula:
(CH2)n
-2- I
CH
/ \
NH C 0 B-
II 2
wherein: n is either 1 or 2,
B- is any group capable of forming an ester linkage, B- is any group capable of forming an ester 3o linkage and cleavable by the thiol proteinase, X is an aliphatic or aromatic hydrophobic group, with an amino acid or derivative thereof or a peptide, the amino acid derivative having a C-terminal protective
group, to obtain a compound of the following general formula:
wherein A is a residue of said amino acid or derivative thereof or said peptide, and optionally removing the X and B, groups from the molecule.
In a preferred embodiment of the invention the thiol proteinase is either papain or chymopapain, n is 1, X is benzyloxycarbonyl (known in the art as Z) , B, and B-, -2- .ι are both benzyl groups, A is a methyl ester of phenylalanine and a hydrogenation process is used to remove the Z and B, benzyl group from the reaction product to produce aspartame.
Thiol proteinases have been well characterized in the literature (e.g. Advances in Enzymology Vol. 53 pp 239-306) , and include the enzymes papain, chymopapain, ficin, bromelain, cathepsins B and C and Streptococcal proteinase. Apart from Z there are a number of other aliphatic or aromatic hydrophobic groups which could be used in this invention. These include t-BOC, B'.poc, and Fmoc. The use and characteristics of these compounds has been described in the literature by Schechter I and Berger A (Biochem. Biphys. Res. Comm. Vol. 27 pp 157-162) and by Fruton J.S. (Advances in Enzymology Vol. 53 pp 239-306).
Examples of groups which can be substituted for benzyl at B, and/or B, are ethyl or methyl groups. However the rate of reaction in the case of production of aspartame is greater when B, and B- are both benzyl. When the method of the present invention is employed to link an aspartate or glutamate radical to a single amino acid derivative, as is the case of the production of aspartame, it is preferable that C-terminal of the amino acid be protected. The protective groups for the carboxyl θ group of this amine component include alkoxy groups, substituted or unsubstituted benzyloxy groups, or amino groups. As will be appreciated by the person skilled in the art when the method of the present invention is employed to link an aspartate or glutamate radical to a peptide it is not necessary to protect the C-terminal of peptide, although this may optionally be done, as the carboxyl group of the amino acid residue of the peptide to which the aspartate or glutamate radical is to be linked is already indirectly protected by the other amino acid Q> residue (s) making up the peptide.
The invention will now be described by means of example. Example 1
(i) Formation of Z-L-aspartyl (/3 -benzyl ester) -L-phenylalanine methyl ester a) 1.0 M Z-L-aspartic acid dibenzyl ester in dimethyl formamide. b) 278mM L-phenylalanine methyl ester in 55% ethanol containing llmM EDTA and 28mM mercapto-ethanol plus 0 5.9uM activated papain, pH8.5.
Reaction 1 part "a" was added to 9 parts "b" at room temperature and the pH maintained at 8.5. Synthesis was monitored by high pressure liquid chromatography (HPLC) . The reaction proceeded with approximately 70 to 80% efficiency in terms of the amount of '-a" used with a
reaction time of approximately 2-3 hours.
The synthesis product Z-L-aspartyl ( β -benzyl ester) -L-phenylalanine methyl ester precipitated during the reaction and was harvested by filtration.
All other reaction products are recoverable and the hydrolysis product Z-L-aspartic acid/3 -benzyl ester can be recycled to reform Z-L-aspartic acid dibenzyl ester. Experiments indicate that the papain is stable under the reaction conditions although it may need to be reactivated \Q periodically.
(i-'i) Conversion to L-aspartyl-L-phenylalanine methyl ester
This conversion was carried out by a hydrogenation reaction involving a palladium catalyst and hydrogen gas.
The entire reaction is summarized in Figure 1.
This method of production of aspartame has a number of advantages over prior art process in that the use of Z-L-aspartic acid dibenzyl ester has advantages over other aspartic acid derivatives. It is a relatively cheap reagent to prepare as both carboxyl groups have the same _2σ substitution. The side chain remains protected after the coupling of the L-phenylalanine methyl ester enabling the product to precipitate. In this regard it should be noted that some prior art processes require the use of addition compounds to cause precipitation e.g. U.S. 4,521,024. Finally both the Z and benzyl groups can be removed from the synthesis product in a single catalytic hydrogenation to yield aspartame Example 2
Formation of Z-L-glutamyl ( -3* -benzyl ester) -L- 3σ phenylalanine methyl ester a) 1.0 M Z-L glutamic acid dibenzyl ester in dimethylfor amide. b) 222 mM L-phenylalanine methyl ester in 44% dimethylformamide containing 11 mM EDTA and 28 mM mercaptoethanol plus 2.4 uM activated papain, pH 8.5.
Reaction
One part of "a" was added to nine parts "b** at room temperature and the pH maintained at 8.5. Synthesis was monitored by HPLC. The reaction proceeded with t approximately 90% efficiency in terms of the amount of "a" used.
The synthesis product Z-L-glutamyl ( - benzyl ester) -L-phenylalanine methyl ester precipitated during the reaction and was harvested by filtration. O Example 3
Formation of Z-L-aspartyl ( /3 -benzyl) -L-alanine ethyl ester. a) 800 mM Z-L-aspartic acid dibenzyl ester in dimethylformamide. b) 222 mM L-alanine ethyl ester in 55% dimethylformamide containing 11 mM EDTA and 28 mM mercaptoethanol plus 2.4 uM activated papain, pH 8.5.
Reaction
One part "a" was added to nine parts "hn at room -i ? temperature and the pH maintained at 8.5. Synthesis was monitored by HPLC. The reaction proceed with approximately 40% efficiency in terms of the amount of "a" incorporated into Z-L-aspartyl ( 3 -benzyl) -L-alanine ethyl ester.
The synthesis product precipitated during the reaction and was harvested by filtration. Example 4 Formation of Z-L-aspartyl (/3 -benzyl ester) -L- serine amide a) 1.0 M Z-L-aspartic acid dibenzyl ester in o dimethylformamide. b) 667 mM L-serine amide in 55% dimethylformamide containing llmM EDTA and 28 mM mercaptoethanol plus
5.9 uM activated papain, pH 8.5. ι
Reaction
One part "a" was added to nine parts "b" at room
temperature and the pH maintained at 8.5. The reaction was monitored by HPLC. The reaction proceeded with approximately 40-50% efficiency in terms of the amount of
"a" incorporated into Z-L-aspartyl ( _? -benzyl) -L- serine amide.
Example 5
Formation of t-BOC-L-aspartyl ( -benzyl ester) -L-alanyl-L-isoleucyl-L-phenylalanine methyl ester a) 1.0 M t-butyloxycarboxyl-L-aspartic acid dibenzyl ester in dimethyl formamide. b) lllmM L-alanyl-L-isoleucyl-L-phenylalanine methyl ester in 55% dimethylformamide containing 28 mM EDTA plus 4.3 uM activated papain, pH 8.5.
Reaction
One part "a" was added to nine parts "b" at room temperature and the pH maintained at 8.5. The reaction was monitored by HPLC. The reaction proceeded with approximately 30-40% efficiency in terms of the amount of •■a" used. The synthesis product t-BOC-L-aspartyl ( _? -benzyl) -L-alanyl-L-isoleucyl-L-phenylalanine methyl ester precipitated during the reaction and was harvested by filtration.
Claims
1. A method for the addition of an aspartate or glutamate radical to the N-terminal of an amino acid, wherein said amino acid exists either singly, as a derivative having a C-terminal protective group, or as the N-terminal residue of a peptide, said method comprising the following steps: reacting, in the presence of a thiol proteinase, a compound of a general formula:
0 0— Bλ
wherein: n is either 1 or 2,
B, is any group capable of forming an ester linkage, B2 is any group capable of forming an ester linkage and cleavable by the thiol proteinase, X is an aliphatic or aromatic hydrophobic group, with an amino acid or derivative thereof or a peptide, the amino acid derivative having a C-terminal protective
group, to obtain a compound of the following general formula:
0 0 B,
(CH2)n
0
wherein A is. a residue of said amino acid or derivative thereof or said peptide, and optionally removing the X and B- groups from the molecule.
2. A method as claimed in claim 1 in which B. and B-, are the same or different and are selected from the group comprising methyl, ethyl and benzyl, and wherein the amino acid derivative has a C-terminal protective group.
3. A method as claimed in claim 1 or 2 in which the thiol proteinase is either papain or chymopapain, and in which X is either benzyloxycarboxyl (Z) or tertiary butyloxy carboxyl (t-BOC) .
4. A method as claimed in claim 3 in which B- and B-, are both benzyl; the thiol protease is papain; and X is Z and in which the X and B, groups are subsequently removed by hydrogenation.
5. A method of producing L-aspartyl-L- phenylalanine methyl ester (aspartame) comprising the steps of: a) reacting Z-L-aspartic acid dibenzyl ester with
L-phenylalanine methyl ester in the presence of papain; b) recovering formed Z-L-aspartyl ( β -benzyl ester) -L-phenylalanine methyl ester; and c) subjecting the recovered product of (b) to a hydrogenation reaction to remove the benzyl and Z groups.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU5408/86 | 1986-04-10 | ||
| AUPH540886 | 1986-04-10 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP0303602A1 EP0303602A1 (en) | 1989-02-22 |
| EP0303602A4 true EP0303602A4 (en) | 1990-06-26 |
Family
ID=3771549
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP19870902325 Withdrawn EP0303602A4 (en) | 1986-04-10 | 1987-04-08 | Enzymatic synthesis. |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0303602A4 (en) |
| JP (1) | JPH01501995A (en) |
| AU (1) | AU591557B2 (en) |
| WO (1) | WO1987006268A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK72587D0 (en) * | 1987-02-13 | 1987-02-13 | Carlsberg Biotechnology Ltd | PROCEDURE FOR ENZYMATIC DIPEPTID PREPARATION |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1337086A (en) * | 1971-05-25 | 1973-11-14 | Tate & Lyle Ltd | Sweet substance |
| US4116768A (en) * | 1975-04-29 | 1978-09-26 | (Zaidanhojin) Sagami Chemical Research Center | Process for producing a peptide |
| US4086136A (en) * | 1975-10-23 | 1978-04-25 | (Zaidanhojin) Sagami Chemical Research Center | Process for producing a peptide using a serine or thiol proteinase |
| RO80806A (en) * | 1979-04-06 | 1983-02-01 | De Forenede Bryggerier As,Dk | PROCEDURE FOR ENZYMATIC OBTAINING PEPTIDES |
| CH647550A5 (en) * | 1979-12-28 | 1985-01-31 | Nestle Sa | PROCESS FOR THE PREPARATION OF AN OLIGO-L-METHIONINE BY THE ENZYMATIC ROUTE AND THE USE THEREOF. |
| IE52242B1 (en) * | 1981-02-02 | 1987-08-19 | Searle & Co | Preparation of amino protected-l-aspartyl-l-phenylalanine alkyl ester |
-
1987
- 1987-04-08 JP JP62502329A patent/JPH01501995A/en active Pending
- 1987-04-08 AU AU72365/87A patent/AU591557B2/en not_active Ceased
- 1987-04-08 EP EP19870902325 patent/EP0303602A4/en not_active Withdrawn
- 1987-04-08 WO PCT/AU1987/000092 patent/WO1987006268A1/en not_active Ceased
Non-Patent Citations (4)
| Title |
|---|
| CHEMICAL ABSTRACTS, vol. 100, no. 1, 2nd January 1984, page 420, abstract no. 4787t, Columbus, Ohio, US; & JP-A-58 146 295 (SAGAMI CHEMICAL RESEARCH CENTER INSTITUTE OF PHYSICAL AND CHEMICAL RESEARCH) 31-08-1983 * |
| CHEMICAL ABSTRACTS, vol. 103, no. 23, 9th December 1985, page 579, abstract no. 194943y, Columbus, Ohio, US; & JP-A-60 41 499 (ASAHI CHEMICAL INDUSTRY CO., LTD) 05-03-1985 * |
| CHEMICAL ABSTRACTS, vol. 91, no. 17, 22nd October 1979, page 696, abstract no. 141244y, Columbus, Ohio, US; & JP-A-79 64 692 (SHIONOGI AND CO., LTD) 24-05-1979 * |
| See also references of WO8706268A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP0303602A1 (en) | 1989-02-22 |
| AU591557B2 (en) | 1989-12-07 |
| AU7236587A (en) | 1987-11-09 |
| JPH01501995A (en) | 1989-07-13 |
| WO1987006268A1 (en) | 1987-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4119493A (en) | Process for producing a peptide | |
| CS254954B2 (en) | Method of peptides production | |
| EP0278787B1 (en) | A process for enzymatic production of dipeptides | |
| US4116768A (en) | Process for producing a peptide | |
| WO1990001555A1 (en) | A process for enzymatic production of dipeptides or structurally related compounds | |
| CA2092721C (en) | Process for the preparation of c-terminally amidated peptides | |
| JPS60164495A (en) | Enzymatic coupling of n-formyl amino acid and peptide residue | |
| Kullmann | Proteases as catalytic agents in peptide synthetic chemistry: Shifting the extent of peptide bond synthesis from a “quantité négligeable” to a “quantité considérable” | |
| AU591557B2 (en) | Enzymatic synthesis | |
| Kuhl et al. | On the use of carboxamidomethyl esters in the protease-catalyzed peptide synthesis | |
| WO1989006656A1 (en) | Enzymatic process for producing immunomodulating pentapeptides and intermediates for use in the process | |
| JP4856184B2 (en) | Enzymatic conversion of oligopeptide amides to oligopeptide alkyl esters | |
| CN101821400B (en) | Chemo-enzymatic peptide synthesis via c-terminal ester interconversion | |
| EP0458475A2 (en) | Transpeptidation reagent and method | |
| EP1123410B1 (en) | The enzyme-mediated synthesis of peptidomimetics | |
| WO1988001650A1 (en) | Enzymatic process | |
| JPH0525480B2 (en) | ||
| CN1178953C (en) | Synthesis and recovery of aspartame involving an enzymatic deformylation step | |
| CN114805477A (en) | Method for synthesizing L-lysyl-L-tyrosine | |
| JPS62232393A (en) | Enzymatic production of peptide derivative | |
| JPS63254994A (en) | Production of n-substituted leucine enkephalinamide | |
| Joshi | Application of proteases for the total enzymatic synthesis of the cholecystokinin octapeptide (CCK-8) using benzoyl-arginine as an enzymatically cleavable N-terminal protecting group | |
| KR20030002010A (en) | Protease-catalyzed synthesis of enkephalin in organic aqueous monophasic system | |
| JPH01228496A (en) | Enzymatic synthesis of peptide | |
| WO2005001107A1 (en) | Method of separating optical isomers of a protected aminoacid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 19880926 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LI LU NL SE |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 19900626 |
|
| 17Q | First examination report despatched |
Effective date: 19920304 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 19920915 |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: WHITTAKER, ROBERT, GEORGE |